Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)

NCT ID: NCT06286761

Last Updated: 2025-07-20

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 100 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2024-05-08
• Study Completion Date: 2028-03-31

Brief Summary

The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases (obesity, pre-diabetes and type-2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, cardiovascular disease, etc.), nutrition, and metabolism (the process by which a substance is handled in your body) at the University of Missouri. As technology changes and we start to use new testing methods, it is necessary to compare results from old tests, equipment and devices and new tests, equipment, or devices and the reproducibility of these measurements to make sure we are getting accurate results. Reproducibility means performing the same test more than once to see if the same results can be achieved each time.

Conditions

Obesity

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Single arm

For blood assay validation and/or reproducibility testing, blood samples will be taken after an overnight fast or after oral glucose or a mixed meal and analyzed. Measurements will be made by: using different assays to determine best conditions of measurement, or repeat testing on different days. Endothelial cells will be collected from a 20-gauge intravenous catheter. One to six 0.025" J-wires will be sequentially inserted into the catheter. These measurements will allow us to determine: the reproducibility and variability of assays used, best timing of blood and endothelial cell collection and best blood volumes and endothelial cell collection wire passes to reliably perform routine assays. For imaging validation, algorithm development, and/or reproducibility testing, participants may undergo DEXA, MRI, or MRS testing to develop or improve analysis algorithms, to evaluate variability of the measurements, or testing different equipment that measure the same variable.

endothelial cell collection

Intervention Type: OTHER

Participants may opt to have testing performed including blood sampling, intravenous catheter placement with endothelial cell collection, oral glucose tolerance test, consuming a test meal, having imaging performed such as MRI, DEXA, MRS to investigate use of different assays, different sample treatment approaches to determine optimal conditions that produce the most accurate and reproducible results, and/or repeat testing on different days or with different equipment that measures the same variable.

Interventions

endothelial cell collection

Participants may opt to have testing performed including blood sampling, intravenous catheter placement with endothelial cell collection, oral glucose tolerance test, consuming a test meal, having imaging performed such as MRI, DEXA, MRS to investigate use of different assays, different sample treatment approaches to determine optimal conditions that produce the most accurate and reproducible results, and/or repeat testing on different days or with different equipment that measures the same variable.

Intervention Type: OTHER

Other Intervention Names

MRI; DEXA; MRS; blood testing; mixed meal; oral glucose tolerance testing

Eligibility Criteria

Inclusion Criteria

• ≥18 and ≤75 years of age
• body mass index ≥18.5 and ≤45 kg/m2
• Weight stable (i.e., ≤3% change)
• ≤150 min of structured exercise/week for at least 2 months before entering the study
• Blood glucose: < 126 mg/dl fasted, < 200 mg/dl with 2 hour oral glucose tolerance testing
• Hemoglobin A1C (HbA1C) ≤6.5%
• Dyslipidemia triglycerides ≥125 mg/dL
• No chronic kidney disease
• Not vegan or vegetarian or on high protein diet (e.g. Atkins) or supplements that are not allowed
• No intolerance or allergies to study diet ingredients
• No excessive alcohol or tobacco consumption

Exclusion Criteria

• <18 and >75 years of age
• body mass index <18.5 or >45 kg/m2
• history of or current significant organ system dysfunction (e.g., heart disease, stroke, diabetes, cancer in remission for <5 years, dementia, chronic kidney disease)
• allergies or intolerances to meal ingredients, vegans or vegetarians
• use of medications that could confound the study outcomes (e.g., anti-inflammatories, immune modulators, etc)
• take dietary supplements (e.g., certain pre- and pro-biotics, fiber, fish oil supplements)
• engaged in regular structured exercise >150 min per week
• alcohol use disorder as defined by the National Institute of Alcohol Abuse and Alcoholism or use of controlled substances
• pregnant women
• persons who use tobacco
• prisoners
• the inability to grant voluntary informed consent.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Bettina Mittendorfer

OTHER

Sponsor Role: lead

Responsible Party

Bettina Mittendorfer

Senior Associate Dean for Research; Professor, Medicine & Nutrition; NextGen Director of Clinical and Translational Sciences Unit

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Bettina Mittendorfer, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Missouri-Columbia

Locations

University of Missouri School of Medicine

Columbia, Missouri, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Heather McHatton, MPH, RN

Role: CONTACT

heathermchatton@health.missouri.edu

(573) 882-7619

Vasavi Shabrish, PhD

Role: CONTACT

v.shabrish@missouri.edu

Facility Contacts

Vasavi Shabrish

Role: primary

v.shabrish@missouri.edu

Other Identifiers

2100332

Identifier Type: -

Identifier Source: org_study_id